PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för SB 415286. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

13 hits

Bibliografisk träff 2013-10-28

Coadministration of glycogen-synthase kinase 3 inhibitor with morphine attenuates chronic morphine-induced analgesic tolerance and withdrawal syndrome.

Liao WW, Tsai SY, Liao CC, Chen KB, Yeh GC, Chen JY, Wen YR.

J Chin Med Assoc · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jcma.2013.09.008

Bibliografisk träff 2013-08-01

Glycogen synthase kinase-3β is involved in C-reactive protein-induced endothelial cell activation.

Liu SJ, Liu WH, Zhong Y, Liu SM.

Biochemistry (Mosc) · research support, non-u.s. gov't; journal article · DOI 10.1134/s0006297913080087

Bibliografisk träff 2013-07-16

Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.

Wang HM, Zhang T, Li Q, Huang JK, Chen RF, Sun XJ.

Neurochem Int · research support, non-u.s. gov't; journal article · DOI 10.1016/j.neuint.2013.07.003

Bibliografisk träff 2012-07-08

Stimulation of bone formation in the expanding premaxillary suture with a GSK-3β inhibitor.

Jiang Y, Liu HX, Guo JJ, Tang GH, Qian YF.

Oral Dis · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1111/j.1601-0825.2012.01957.x

Bibliografisk träff 2008-10-01

Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells.

Beurel E, Blivet-Van Eggelpoël MJ, Kornprobst M, Moritz S, Delelo R, Paye F, Housset C, Desbois-Mouthon C.

Biochem Pharmacol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/j.bcp.2008.09.026

Bibliografisk träff 2008-04-11

GSK-3 beta inhibition and prevention of mitochondrial apoptosis inducing factor release are not involved in the antioxidant properties of SB-415286.

Yeste-Velasco M, Folch J, Jiménez A, Rimbau V, Pallàs M, Camins A.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2008.04.019

Bibliografisk träff 2008-02-08

Neuroprotective effects of SB-415286 on hydrogen peroxide-induced cell death in B65 rat neuroblastoma cells and neurons.

Pizarro JG, Yeste-Velasco M, Rimbau V, Casadesús G, Smith MA, Pallàs M, Folch J, Camins A.

Int J Dev Neurosci · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijdevneu.2008.02.002

Bibliografisk träff 2005-04-26

Inhibition of GSK3beta is a common event in neuroprotection by different survival factors.

Chin PC, Majdzadeh N, D'Mello SR.

Brain Res Mol Brain Res · research support, u.s. gov't, p.h.s.; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1016/j.molbrainres.2005.03.004

Bibliografisk träff 2004-02-01

Glycogen synthase kinase-3 regulates cytoskeleton and translocation of Rac1 in long cellular extensions of human keratinocytes.

Koivisto L, Häkkinen L, Matsumoto K, McCulloch CA, Yamada KM, Larjava H.

Exp Cell Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.yexcr.2003.09.026

Bibliografisk träff 2003-09-01

Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase.

MacAulay K, Hajduch E, Blair AS, Coghlan MP, Smith SA, Hundal HS.

Eur J Biochem · research support, non-u.s. gov't; journal article · DOI 10.1046/j.1432-1033.2003.03777.x

Bibliografisk träff 2003-08-01

Glycogen synthase kinase-3 inhibitors protect central neurons against excitotoxicity.

Facci L, Stevens DA, Skaper SD.

Neuroreport · research support, non-u.s. gov't; journal article · DOI 10.1097/00001756-200308060-00012

Bibliografisk träff 2001-11-01

GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity.

Culbert AA, Brown MJ, Frame S, Hagen T, Cross DA, Bax B, Reith AD.

FEBS Lett · journal article · DOI 10.1016/s0014-5793(01)02990-8

Bibliografisk träff 2001-04-01

Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death.

Cross DA, Culbert AA, Chalmers KA, Facci L, Skaper SD, Reith AD.

J Neurochem · journal article · DOI 10.1046/j.1471-4159.2001.t01-1-00251.x